ReviewPharmaceutics2022

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars.

Zvonimir Petric et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.